Monetary Management Group Boosted Its Celgene (CELG) Holding; Ubs Global Asset Management Americas Has Decreased Its Biotelemetry (BEAT) Holding

April 24, 2018 - By Vivian Park

BioTelemetry, Inc. (NASDAQ:BEAT) Logo

Ubs Global Asset Management Americas Inc decreased Biotelemetry Inc (BEAT) stake by 46.26% reported in 2017Q4 SEC filing. Ubs Global Asset Management Americas Inc sold 6,456 shares as Biotelemetry Inc (BEAT)’s stock rose 1.79%. The Ubs Global Asset Management Americas Inc holds 7,500 shares with $224.25 million value, down from 13,956 last quarter. Biotelemetry Inc now has $1.08 billion valuation. The stock decreased 1.79% or $0.6 during the last trading session, reaching $33. About 161,365 shares traded. BioTelemetry, Inc. (NASDAQ:BEAT) has risen 11.39% since April 24, 2017 and is uptrending. It has underperformed by 0.16% the S&P500.

Monetary Management Group Inc increased Celgene Corp (CELG) stake by 32.72% reported in 2017Q4 SEC filing. Monetary Management Group Inc acquired 10,735 shares as Celgene Corp (CELG)’s stock declined 19.30%. The Monetary Management Group Inc holds 43,540 shares with $4.54M value, up from 32,805 last quarter. Celgene Corp now has $67.16B valuation. The stock decreased 0.22% or $0.19 during the last trading session, reaching $89.29. About 2.56M shares traded. Celgene Corporation (NASDAQ:CELG) has declined 31.28% since April 24, 2017 and is downtrending. It has underperformed by 42.83% the S&P500.

Since February 8, 2018, it had 1 insider purchase, and 3 sales for $3.58 million activity. LOUGHLIN JAMES J had sold 9,250 shares worth $851,093. 18,500 shares were sold by KAPLAN GILLA, worth $1.77M. Alles Mark J had bought 3,260 shares worth $299,594 on Thursday, February 8. MARIO ERNEST had sold 13,370 shares worth $1.26M.

Among 34 analysts covering Celgene Corporation (NASDAQ:CELG), 19 have Buy rating, 1 Sell and 14 Hold. Therefore 56% are positive. Celgene Corporation had 142 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Jefferies given on Monday, July 10. The firm has “Buy” rating by BMO Capital Markets given on Monday, January 8. The rating was maintained by Jefferies on Friday, June 23 with “Buy”. JMP Securities maintained Celgene Corporation (NASDAQ:CELG) rating on Wednesday, March 9. JMP Securities has “Market Outperform” rating and $152 target. The rating was maintained by Oppenheimer with “Buy” on Thursday, July 27. The firm has “Buy” rating by SunTrust given on Friday, December 22. RBC Capital Markets maintained the shares of CELG in report on Thursday, October 19 with “Buy” rating. Piper Jaffray maintained the stock with “Hold” rating in Thursday, January 25 report. The firm has “Outperform” rating given on Monday, October 30 by Oppenheimer. The stock of Celgene Corporation (NASDAQ:CELG) earned “Underweight” rating by Morgan Stanley on Monday, October 23.

Monetary Management Group Inc decreased Walgreen Boots Alliance Inc. stake by 28,900 shares to 20,100 valued at $1.46 million in 2017Q4. It also reduced Monster Beverages stake by 31,960 shares and now owns 4,075 shares. Allergan was reduced too.

Investors sentiment decreased to 0.83 in Q4 2017. Its down 0.34, from 1.17 in 2017Q3. It is negative, as 156 investors sold CELG shares while 478 reduced holdings. 118 funds opened positions while 411 raised stakes. 561.38 million shares or 7.06% less from 603.99 million shares in 2017Q3 were reported. Caisse De Depot Et Placement Du Quebec reported 68,322 shares or 0.02% of all its holdings. Investment Mgmt Of Virginia holds 1.33% of its portfolio in Celgene Corporation (NASDAQ:CELG) for 53,616 shares. The Florida-based State Board Of Administration Of Florida Retirement Systems has invested 0.3% in Celgene Corporation (NASDAQ:CELG). Carroll holds 0.02% or 1,387 shares in its portfolio. Diversified accumulated 2,446 shares. Weatherstone has 3,899 shares. 8,470 were accumulated by Broderick Brian C. Syntal Cap Ptnrs Ltd Company has 0.12% invested in Celgene Corporation (NASDAQ:CELG) for 3,900 shares. Smith Asset Management Gru LP owns 6,900 shares. Davidson Invest Advsrs invested in 0.79% or 72,875 shares. Dillon & Assocs reported 52,044 shares. Fiera Capital invested 0.04% in Celgene Corporation (NASDAQ:CELG). Geode Management Ltd Liability Company, Massachusetts-based fund reported 8.31M shares. Lombard Odier Asset Mgmt (Switzerland) Sa reported 52,949 shares stake. Highland Cap Management Ltd Liability Com has invested 0.55% in Celgene Corporation (NASDAQ:CELG).

Among 6 analysts covering BioTelemetry (NASDAQ:BEAT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioTelemetry had 10 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of BioTelemetry, Inc. (NASDAQ:BEAT) earned “Buy” rating by Dougherty on Friday, February 23. Dougherty & Company maintained the shares of BEAT in report on Tuesday, April 11 with “Buy” rating. As per Friday, December 2, the company rating was initiated by Dougherty & Company. The rating was maintained by Dougherty & Company with “Buy” on Tuesday, July 28. Sidoti initiated BioTelemetry, Inc. (NASDAQ:BEAT) on Tuesday, September 13 with “Buy” rating. The stock has “Buy” rating by Raymond James on Thursday, November 30.

Investors sentiment decreased to 0.88 in 2017 Q4. Its down 0.40, from 1.28 in 2017Q3. It dropped, as 47 investors sold BEAT shares while 57 reduced holdings. 27 funds opened positions while 65 raised stakes. 27.71 million shares or 8.71% more from 25.49 million shares in 2017Q3 were reported. Swiss Retail Bank holds 50,800 shares or 0% of its portfolio. Tci Wealth Advsrs owns 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 53 shares. Invesco Limited owns 0% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 88,420 shares. 24,642 were accumulated by Us Bank & Trust De. Fortaleza Asset Mgmt owns 3,505 shares. Credit Suisse Ag accumulated 576,198 shares. Glenmede Tru Co Na reported 0.13% in BioTelemetry, Inc. (NASDAQ:BEAT). Gabelli Funds Lc holds 98,000 shares or 0.02% of its portfolio. Perkins Cap has 0.43% invested in BioTelemetry, Inc. (NASDAQ:BEAT) for 15,000 shares. Principal Fincl Gru reported 249,022 shares or 0.01% of all its holdings. Alliancebernstein Ltd Partnership invested 0% in BioTelemetry, Inc. (NASDAQ:BEAT). Ubs Asset Americas holds 0% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT) for 7,500 shares. Public Sector Pension Investment Board reported 0% of its portfolio in BioTelemetry, Inc. (NASDAQ:BEAT). Farmers Merchants Invs holds 257 shares or 0% of its portfolio. Susquehanna Intl Grp Inc Limited Liability Partnership invested in 0% or 137,408 shares.

Analysts await BioTelemetry, Inc. (NASDAQ:BEAT) to report earnings on May, 2. They expect $0.25 earnings per share, up 56.25% or $0.09 from last year’s $0.16 per share. BEAT’s profit will be $8.18M for 33.00 P/E if the $0.25 EPS becomes a reality. After $0.32 actual earnings per share reported by BioTelemetry, Inc. for the previous quarter, Wall Street now forecasts -21.88% negative EPS growth.

Ubs Global Asset Management Americas Inc increased Quad Graphics Inc (NYSE:QUAD) stake by 1,217 shares to 10,156 valued at $229.53M in 2017Q4. It also upped Eagle Bancorp Inc (NASDAQ:EGBN) stake by 4,386 shares and now owns 21,144 shares. Imperva Inc (NYSE:IMPV) was raised too.

BioTelemetry, Inc. (NASDAQ:BEAT) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>